Home » Topics » Regulatory » Patents

Patents
RSS

Chinese investigators divulge EGFR inhibitors

Jan. 12, 2021

AMMS synthesizes new adenosine A2A receptor agonists

Jan. 11, 2021

Indian researchers patent new lipoxygenase inhibitors

Jan. 11, 2021

Calithera Biosciences presents CD73 inhibitors

Jan. 11, 2021

Bristol Myers Squibb discloses new FPR2 agonists

Jan. 11, 2021

Dana-Farber Cancer Institute patents EGFR allosteric inhibitors

Jan. 11, 2021

BioWorld MedTech Patent Highlights: Week 53

From Current Patent Gazette

Jan. 8, 2021

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

ViiV Healthcare discovers compounds for HIV infection

Jan. 8, 2021

Pfizer and CTxT Pty synthesize KAT inhibitors

Jan. 8, 2021

GlaxoSmithKline plc discloses new antibacterials

Jan. 8, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...